SARS-COV-2 NUCLEOCAPSID ANTIBO
|
SARS-CoV-2 Nucleocapsid, Host: Human, Applications: ELISA, WB, Clone: bcn05, Species Reactivity: Virus, Monoclonal, Primary, 0.35 mg/mL, 100 ug, Unconjugated, Invitrogen
|
3136-MA535954
|
EA
|
|
SARS-COV-2 NUCLEOCAPSID ANTIBO
|
SARS-CoV-2 Nucleocapsid, Host: Human, Applications: ELISA, WB, Clone: bcn11, Species Reactivity: Virus, Monoclonal, Primary, 0.33 mg/mL, 100 ug, Unconjugated, Invitrogen
|
3136-MA535953
|
EA
|
|
SARS-COV-2 NUCLEOCAPSID RECOMB
|
SARS-CoV-2 Nucleocapsid, Recombinant Protein, Invitrogen, Conjugate: Unlabeled, Format: Liquid, Formulation: PBS with no preservative; pH 7.4, Quantity: 1 mg, Recombinant: Yes, Regulatory Status: RUO, Applications: Control, Western Blot
|
3136-RP87665
|
EA
|
|
SARS-COV-2 NUCLEOCAPSID ANTIBO
|
SARS-CoV-2 Nucleocapsid, Host: Human, Applications: ELISA, WB, Clone: bcn14, Species Reactivity: Virus, Monoclonal, Primary, 0.42 mg/mL, 100 ug, Unconjugated, Invitrogen
|
3136-MA535955
|
EA
|
|
SARS-COV-2 NUCLEOCAPSID HIS T
|
SARS-CoV-2 Nucleocapsid, His Tag, Recombinant Protein, Invitrogen, Conjugate: Unlabeled, Format: Liquid, Formulation: PBS with no preservative; pH 7.4, Quantity: 1 mg, Recombinant: Yes, Regulatory Status: RUO, Applications: Control, ELISA,
|
3136-RP87669
|
EA
|
|